Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica iito 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 39 40 41 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Biofrontera–SEVERAL: investment, 201203 private placement capital increase €11.5m 4.4m new shares 2012-03-02
Innovative Medicines Initiative–EU (govt): grant, 201203– funding €18.2m for ABIRISK project by IMI of €34.9m total cost 2012-03-01
Boehringer–Biocrea: PDE-2 inhibitors, 201202– acquisition €na asset purchase of Biocrea’s PDE2 inhibitors incl lead compound BCA909 2012-02-29
Danaher–Epitomics: RabMab technology, 201202– collab supply long-term rabbit MAbs for automated ICH staining systems of Leica Biosystems 2012-02-29
Lundbeck–Paion: desmoteplase, 201202 acquisition all remaining desmoteplase rights for €20.1m in cash from Paion 2012-02-28
Origenis–Germany (govt): grant, 201202– 2-year grant within m4 Cluster program to develop biomarkers for developm of LRRK2 inhibitors 2012-02-28
Axolabs–Solvay: oligonucleotide drugs, 201202– collab strategic alliance combined services lead optimisation + manuf + analytical expertise Girindus 2012-02-27
OTHER–MorphoSys: Slonomics technology, 201202– supply 3y delivery of multiple Slonomics-based DNA libraries to large biopharma company 2012-02-27
Helmholtz–Bruker Corp: mass spectrometer, 201202 supply existent Ultraflex III MALDI-TOF-TOF at Proteomics Core Facility at Helmholtz München 2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4000 QTRAP at Proteomics Core Facility at Helmholtz-Zentrum München 2012-02-26
Helmholtz–Danaher: mass spectrometer, 201202 supply existent AB Sciex 4700 Proteomics Analyzer at Dept Protein Sciences at Helmholtz-Zentrum München 2012-02-26
Helmholtz–Thermo Fisher: mass spectrometer, 201202 supply existent LTQ Orbitrap XL at Proteomics Core Facility at Helmholtz-Zentrum München 2012-02-26
Apceth–Indivumed: biomarker, 201202– collab developm tissue-based markers for solid cancers to predict response to cell/gene therapy 2012-02-22
Kairos GmbH–Univ Bochum: CentraXX web portal platform, 201202– collab further development of platform with MPC 2012-02-22
Novartis–Enanta Pharmaceuticals: HCV drug, 201202– collab + license ww $34m upfront + $406m milestones + royalties NS5A inhibitor EDP-239 2012-02-21
Xencor–Boehringer: rec protein production, 201202– service + collab developm + manufacture + supply of mABs using Xtend technology for Xencor 2012-02-21
Bayer–Texas A&M Univ: wheat breeding, 201202– collab multi-year €na developm + commercialisation of new wheat varieties Texas AgriLife Research 2012-02-17
Seiratherm–Bavaria (govt): investment, 201202 financing round with investors HTGF + Bayern Kapital 2012-02-17
Seiratherm–High-Tech Gründerfonds: investment, 201202 financing round with investors HTGF + Bayern Kapital 2012-02-17
Seiratherm–SEVERAL: investment, 201202 financing round with HTGF + Bayern Kapital + strategic investor 2012-02-17
Evotec–IR Pharma: drug discovery services, 201202– collab excl strategic alliance €na integrated drug discovery solutions for respiratory diseases 2012-02-16
KMG Chemicals–Bayer: investment, 201202 acquisition €na animal insecticide business of KMG 2012-02-16
Univ Washington–Biognosys: iRT technology, 201202 collab product integration iRT concept implemented in Skyline s/w Vers 1.2 2012-02-16
BASF–Direvo Industrial Biotechnology: feed enzymes, 201202 acquisition of optimised mannanase enzyme by BASF Animal Nutrition business 2012-02-14
4DCellFate project–EU (govt): grant, 201202– 5y FP7 grant €12m 2012-02-13
Agilent–Eppendorf: thermal cycler, 201202– license covering gradient technology for thermal cyclers to Agilent 2012-02-13
OakLabs–High-Tech Gründerfonds: investment, 201202 seed investment from HTGF 2012-02-08
Ramcon–Anagnostics: hybcell products, 201202– collab excl distribution of hybcell tests in Scandinavia by Ramcon A/S 2012-02-08
Desitin–Biofrontera: Ameluz, 201202– excl distribution + marketing in Denmark + Sweden + Norway by Desitin 2012-02-06
Materlab–Biocrates: metabolomics, 201202– collab distribution + co-marketing rights in Spain for Materlab for all Biocrates kits 2012-02-06
Onkogen Diagnostik–Biocrates: metabolomics, 201202– collab distribution + co-marketing rights in Turkey for Onkogen for all Biocrates kits 2012-02-06
Tecan–Artel: liquid handling technology, 201202– collab developm QC Kit for Freedom EVO based on Ratiometric Photometry technology 2012-02-06
Wilex–Germany (govt): grant, 201202– BMBF funding of up to €2.6m for developm of WX-037 within m4 Cluster Initiative 2012-02-06
Biofrontera–SEVERAL: investment, 201202 private placement capital increase €1.5m 500k new shares 2012-02-03
Merck (DE)–Threshold Pharmaceuticals: TH-302, 201202– co-developm + excl ww commercialistion €19m upfront + €41.5m milestones + double-digit royalties 2012-02-03
Anergis–Akampion: public relations, 201202 supply service existent 2012-02-01
BF Holding–SEVERAL: investment, 201202 capital increase MagForce AG €4.54m via 825.4k new shares at €5.5/share 2012-02-01
CovalX–Switzerland (govt): grant, 201202– KTI grant €300k for co-developm methods analysis of protein-protein interactions w Swiss academic partner 2012-02-01
Jacobs Univ–EU (govt): grant, 201202–201601 FP7 grant for Jacobs Univ as project partner + co-ordinator of €9m Micro B3 project 2012-02-01
Max Planck–EU (govt): grant, 201202–201601 FP7 grant for MPI for Marine Microbiology as partner of €9m Micro B3 project 2012-02-01
Micro B3 project–EU (govt): grant, 201202–201601 FP7 grant €9m to create integrative database on marine microorganisms 2012-02-01
Micro B3 project–Jacobs Univ: marine microorganism database, 201202–201601 collab Jacobs Univ is partner + co-ordinator of Micro B3 FP7 project 2012-02-01
Micro B3 project–Max Planck: marine microorganism database, 201202–201601 collab MPI for Marine Microbiology is project partner 2012-02-01
Micro B3 project–Ribocon: marine microorganism database, 201202–201601 collab Ribocon GmbH is project partner 2012-02-01
Ribocon–EU (govt): grant, 201202–201601 FP7 grant for Ribocon GmbH as partner of €9m Micro B3 project 2012-02-01
B Braun–CeGaT: personalised medicine, 201201– collab strategic partnership to expand + internationalise CeGaT’s business 2012-01-31
CeGaT–B Braun: investment, 201201 acquisition of 20% share as part of strategic partnership to expand + internationalise CeGaT’s business 2012-01-31
Implandata–High-Tech Gründerfonds: investment, 201201 financing round Series A first closing totalling €1.4m incl investor HTGF 2012-01-30
Implandata–SEVERAL: investment, 201201 financing round Series A first closing €1.4m HTGF + Hannover Beteiligungsfonds + private investors 2012-01-30
Roche–Curis: vismodegib, 201201 collab existent developm of Erivedge which has been discovered by Genentech 2012-01-30
Roche–Hamilton: lab automation technology, 201201 collab existent product integration for DNA sample enrichment solution 2012-01-30
Bruker Corp–Siscapa: SISCAPA assay technology, 201201 collab developm for MALDI-TOF MS for proteomic marker validation + clin research 2012-01-27
Analytik Jena–Thuringia (govt): investment, 201201–201202 capital increase €4.9m 470k shares €10.48/share TIB increases bm-t share 10.41 to 17.79% 2012-01-26
Hecus X-Ray Systems–Bruker Corp: investment, 201201 acquisition of assets €na by Bruker AXS GmbH from founder + owner Peter Laggner 2012-01-26
Micromet–Amgen: investment, 201201–201203 acquisition $1.16b cash tender offer $11/share 2012-01-26
Illumina–Roche: investment, 201201–201204 unsolicited cash tender offer $5.7b $44.5/share raised to $51/share NOT REALISED 2012-01-25
Spectrum Pharmaceuticals–Bayer: ibritumomab tiuxetan, 201201– acqu ww marketing rights w addit license for Zevalin outside US from Bayer HealthCare 2012-01-25
Immatics–Huntsworth: public relations, 201201 service existent by Citigate Dewe Rogerson 2012-01-24
Labcyte–Qiagen: siRNA libraries, 201201– collab product integration Qiagen siRNA libraries available in Labcyte Echo qualified microplates 2012-01-24
Sartorius–Refine Technology: cell culture technology, 201201– collab product integration of ATF System with BIOSTAT bioreactors 2012-01-23
Oroxcell–Thermo Fisher: mass spectrometer, 201201 supply existent TSQ Quantum Ultra triple quad LC-MS/MS listed as equipment on web site 2012-01-20
Oroxcell–Waters: mass spectrometer, 201201 supply existent Quattro Micro triple quad LC-UV-MS/MS-Radiodetector listed as equipment on web site 2012-01-20
Oroxcell–Waters: mass spectrometer, 201201 supply existent ZMD single quad LC-UV-MS listed as equipment on web site 2012-01-20
Roche–Technoclone: coagulation diagnostics, 201201– collab strategic alliance 2012-01-19
Bruker Corp–SEVERAL: credit, 201201–201701 Senior Notes $20m 3.16% Series 2012A Tranche A due 18 Jan 2017 2012-01-18
Bruker Corp–SEVERAL: credit, 201201–201901 Senior Notes $15m 3.74% Series 2012A Tranche B due 18 Jan 2019 2012-01-18
Bruker Corp–SEVERAL: credit, 201201–202201 Senior Notes $105m 4.31% Series 2012A Tranche C due 18 Jan 2022 2012-01-18
Bruker Corp–SEVERAL: credit, 201201–202401 Senior Notes $100m 4.46% Series 2012A Tranche D due 18 Jan 2024 2012-01-18
Nova Capital–Eppendorf: thermal cycler, 201201– license covering gradient technology for thermal cyclers to Bibby Scientifc Ltd 2012-01-18
Polyplus-transfection–Andrew Lloyd Associates: public relations, 201201 service existent by ALA 2012-01-18
Sartorius–G-Con Manufacturing: cleanroom technology, 201201– collab ww product integration + offering of biopharma manufacturing solutions SSB 2012-01-18
Bayer–Roche: molecular companion diagnostics, 201201– collab developm of IHC companion diagnostic for new Bayer cancer antibody-drug conjugate Ventana 2012-01-17
BBG/Braun Group–Enzymicals: fine chemicals, 201201– collab biocatalytic processes integration of know-how of Herbrand PharmaChemicals + Enzymicals 2012-01-17
Waters–Tecan: liquid handling technology, 201201– supply €na OEM Freedom EVO platform for Waters clinical lab assays with ACQUITY TQD LS/MS/MS 2012-01-17
Bayer–Nomad Bioscience: investment, 201201 acquisition €na all assets + obligations of Icon Genetics GmbH from Bayer Innovation by Nomad Bioscience 2012-01-12
BioMedTec Wissenschaftscampus–Univ Lübeck: medical technology, 201201– Koop Univ Lübeck is founding partner 2012-01-12
Univ Lübeck–Euroimmun: medical technology, 201201– collab Euroimmun AG is founding partner of BioMedTec Wissenschaftscampus Lübeck 2012-01-12
Univ Lübeck–FH Lübeck: medical technology, 201201– collab FH Lübeck is founding partner of BioMedTec Wissenschaftscampus Lübeck 2012-01-12
Univ Lübeck–Fraunhofer: medical technology, 201201– collab Fraunhofer EMB is founding partner of BioMedTec Wissenschaftscampus 2012-01-12
Univ Lübeck–Fraunhofer: medical technology, 201201– collab Fraunhofer MEVIS Bildregistrierung is founding partner of BioMedTec Wissenschaftscampus 2012-01-12
Univ Lübeck–Leibniz-Gemeinschaft: medical technology, 201201– collab Research Center Borstel is founding partner of BioMedTec Wissenschaftscampus 2012-01-12
Organobalance–Comago: public relations, 201201 supply service existent 2012-01-11
Sanofi–Organobalance: yeast technology, 201201– license excl for vaccine production of modified S. cerevisiae strain to Sanofi Pasteur 2012-01-11
Qiagen–Insight Genetics: genomic biomarker, 201201– license excl ww for genetic test inc ALK marker for PDx in lung cancer 2012-01-10
Qiagen–Personal Genome Diagnostics: genomic biomarker, 201201– license excl ww to Ipsogen for IDH1/IDH2 marker for PDx in brain + other cancers 2012-01-10
Telormedix–Avaris: investment, 201201 financing round totalling CHF7.5m from existing investors Aravis Venture + ProQuest Investments 2012-01-10
Telormedix–ProQuest Investments: investment, 201201 financing round totalling CHF7.5m from existing investors Aravis Venture + ProQuest 2012-01-10
Telormedix–SEVERAL: investment, 201201 financing round CHF7.5m from existing investors Aravis Venture + ProQuest Investments 2012-01-10
Dualsystems Biotech–Nikem Research: drug discovery services, 201201– collab strategic alliance combined offering of profiling + discovery services 2012-01-09
JnJ–Proteros: drug discovery services, 201201– supply lead discovery services expanded to global long-term agreem w Janssen R&D 2012-01-09
Qiagen–Max Planck: molecular diagnostics, 201201– collab developm test for active TB risk w latent infection w MPI for Infection Biology 2012-01-09
Wilex–SEVERAL: investment, 201201–201202 capital increase €9.93m with 3.2m new authorised shares €3.1/share 2012-01-09
AMP-Therapeutics–Boehringer: investment, 201201 financing round Series A from Boehringer Ingelheim Venture Fund + Novartis Venture Funds 2012-01-05
AMP-Therapeutics–Novartis: investment, 201201 financing round Series A from Boehringer Ingelheim Venture Fund + Novartis Venture Funds 2012-01-05
AMP-Therapeutics–SEVERAL: investment, 201201 financing round Series A from Boehringer Ingelheim Venture Fund + Novartis Venture Funds 2012-01-05
Apogenix–SEVERAL: investment, 201201 financing round €7.5m lead investor Dievini Hopp Biotech Holding 2012-01-05
Boehringer–Forma Therapeutics: cancer drugs, 201201– collab r+d $65m upfront + funding + $750m milestones small-molecule cancer drugs 2012-01-05
Probiodrug–SEVERAL: investment, 201201 financing round €15m from existing investors + new investor Wellington Management 2012-01-04
Apogenix–Germany (govt): grant, 201201 BMBF grant €2.3m for developm of APG101 for myelodysplastic syndromes 2012-01-03
Bayer–Cellectis: Meganuclease technology, 201201– collab extension €na use to develop agricultural seeds Bayer CropScience + Cellectis Plant Sciences 2012-01-03
next pagenext page 1 2 3 ... 39 40 41 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top